amlodipine 5 MG / hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet
- RxCUI
- 1000001
- RxNorm name
- amlodipine 5 MG / hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet
- Display name
- amLODIPine/hydroCHLOROthiazide/Olmesartan (Oral Pill)
- Full name
- amlodipine 5 MG / hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet
- Term type
- SCD
- Status
- Active
- Strength
- 5-25-40 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-10-24 12:25:15
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| amlodipine besylate | 5 MG / 1 EACH | amlodipine | amlodipine |
| olmesartan medoxomil | 40 MG / 1 EACH | olmesartan | olmesartan medoxomil |
| hydrochlorothiazide | 25 MG / 1 EACH | hydrochlorothiazide | hydrochlorothiazide |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| amlodipine | 17767 |
| olmesartan | 321064 |
| hydrochlorothiazide | 5487 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | amLODIPine 5 MG / hydroCHLOROthiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | amlodipine 5 MG / hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 9 linked values
| 9 | CODES |
| RxCUI | 1000001 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0093-5004-56 | 0093-5004 | Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | ANDA202491 |
| 31722-894-30 | 31722-894 | Olmesartan medoxomil, amlodipine and hydrochlorothiazide Olmesartan medoxomil, amlodipine and hydrochlorothiazide | Camber Pharmaceuticals, Inc. | ANDA209242 |
| 31722-894-32 | 31722-894 | Olmesartan medoxomil, amlodipine and hydrochlorothiazide Olmesartan medoxomil, amlodipine and hydrochlorothiazide | Camber Pharmaceuticals, Inc. | ANDA209242 |
| 31722-894-90 | 31722-894 | Olmesartan medoxomil, amlodipine and hydrochlorothiazide Olmesartan medoxomil, amlodipine and hydrochlorothiazide | Camber Pharmaceuticals, Inc. | ANDA209242 |
| 33342-245-07 | 33342-245 | Olmesartan medoxomil Amlodipine and Hydrochlorothiazide Olmesartan medoxomil Amlodipine and Hydrochlorothiazide | Macleods Pharmaceuticals Limited | ANDA207088 |
| 33342-245-10 | 33342-245 | Olmesartan medoxomil Amlodipine and Hydrochlorothiazide Olmesartan medoxomil Amlodipine and Hydrochlorothiazide | Macleods Pharmaceuticals Limited | ANDA207088 |
| 42571-247-05 | 42571-247 | OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Olmesartan Medoxomil, Amlodipine besylate and Hydrochlorothiazide | Micro Labs Limited | ANDA207437 |
| 42571-247-10 | 42571-247 | OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Olmesartan Medoxomil, Amlodipine besylate and Hydrochlorothiazide | Micro Labs Limited | ANDA207437 |
| 42571-247-30 | 42571-247 | OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Olmesartan Medoxomil, Amlodipine besylate and Hydrochlorothiazide | Micro Labs Limited | ANDA207437 |
| 42571-247-90 | 42571-247 | OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Olmesartan Medoxomil, Amlodipine besylate and Hydrochlorothiazide | Micro Labs Limited | ANDA207437 |
| 49884-788-09 | 49884-788 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Par Health USA, LLC | ANDA206137 |
| 49884-788-11 | 49884-788 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Par Health USA, LLC | ANDA206137 |
| 63629-2241-1 | 63629-2241 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Bryant Ranch Prepack | ANDA206137 |
| 70436-016-04 | 70436-016 | olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide | Slate Run Pharmaceuticals, LLC | ANDA210718 |
| 70436-016-06 | 70436-016 | olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide | Slate Run Pharmaceuticals, LLC | ANDA210718 |
| 70518-4165-0 | 70518-4165 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | REMEDYREPACK INC. | ANDA206137 |
| 72162-1515-3 | 72162-1515 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Bryant Ranch Prepack | ANDA206137 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA202491 | 0093-5004 | Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide | ANDA | Teva Pharmaceuticals USA, Inc. |
| ANDA209242 | 31722-894 | Olmesartan medoxomil, amlodipine and hydrochlorothiazide Olmesartan medoxomil, amlodipine and hydrochlorothiazide | ANDA | Camber Pharmaceuticals, Inc. |
| ANDA207088 | 33342-245 | Olmesartan medoxomil Amlodipine and Hydrochlorothiazide Olmesartan medoxomil Amlodipine and Hydrochlorothiazide | ANDA | Macleods Pharmaceuticals Limited |
| ANDA207437 | 42571-247 | OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Olmesartan Medoxomil, Amlodipine besylate and Hydrochlorothiazide | ANDA | Micro Labs Limited |
| ANDA206137 | 49884-788 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | ANDA | Par Health USA, LLC |
| ANDA210718 | 70436-016 | olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide | ANDA | Slate Run Pharmaceuticals, LLC |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olmesartan medoxomil, amlodipine and hydrochlorothiazide | OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE | Camber Pharmaceuticals, Inc. | 45e975ff-07b1-411a-96ee-a011d1619b1e | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | 31722-894-90 31722-894-30 31722-894-32 31722-894 31722089432 31722089490 31722089430 31722089431 1000001 |
| OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE | Micro Labs Limited | 9fb71df8-f70f-47dc-9465-8d8748261caf | 2025-11-29 | Boxed warning, Warnings, Adverse reactions | 42571-247-05 42571-247-90 42571-247-30 42571-247-10 42571-247 42571024730 42571024790 42571024705 42571024710 1000001 |
| Olmesartan medoxomil Amlodipine and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | 52c013e1-8c31-4bed-9241-e7845873ebe8 | 2025-08-04 | Boxed warning, Warnings, Adverse reactions | 33342-245-10 33342-245-07 33342-245 33342024510 33342024507 1000001 |
| olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE | Slate Run Pharmaceuticals, LLC | a469adff-25a6-4983-b471-60924d920a86 | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | 70436-016-06 70436-016-04 70436-016 70436001606 70436001604 1000001 |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 49ec5ac8-a626-4ab2-9799-8a138920201e | 2024-11-06 | Boxed warning, Warnings, Adverse reactions | 72162-1515-3 72162-1515 72162151503 1000001 |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | be69f132-8b77-4590-a688-cb3709649466 | 2024-08-06 | Boxed warning, Warnings, Adverse reactions | 63629-2241-1 63629-2241 63629224101 1000001 |
| Tribenzor | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Cosette Pharmaceuticals, Inc. | 2f56d0bc-236b-41a0-9fc0-21cdfea8d890 | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 1000001 |
| Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE | Teva Pharmaceuticals USA, Inc. | 5c128ef2-60a6-40f3-b37f-ee139fe27987 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 0093-5004-56 0093-5004 00093500456 1000001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| be69f132-8b77-4590-a688-cb3709649466 | olmesartan medoxomil 40 MG / amLODIPine 5 MG / hydroCHLOROthiazide 25 MG Oral Tablet [PSN] · amlodipine 5 MG / hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SCD] · amlodipine (as amlodipine besilate) 5 MG / HCTZ 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SY] · Amlodipine 5 MG / HCTZ 25 MG / Olmesartan medoxomil 40 MG Oral Tablet [SY] | 4 | 105 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS Tablets, for oral use Initial U.S. Approval: 2010 | 20240806 |
| 49ec5ac8-a626-4ab2-9799-8a138920201e | olmesartan medoxomil 40 MG / amLODIPine 5 MG / hydroCHLOROthiazide 25 MG Oral Tablet [PSN] · amlodipine 5 MG / hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SCD] · amlodipine (as amlodipine besilate) 5 MG / HCTZ 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SY] · Amlodipine 5 MG / HCTZ 25 MG / Olmesartan medoxomil 40 MG Oral Tablet [SY] | 4 | 103 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS Tablets, for oral use Initial U.S. Approval: 2010 | 20241106 |
| 268d12e8-1cfc-4086-b613-8fd94f2d7c4e | olmesartan medoxomil 40 MG / amLODIPine 5 MG / hydroCHLOROthiazide 25 MG Oral Tablet [PSN] · amlodipine 5 MG / hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SCD] · amlodipine (as amlodipine besilate) 5 MG / HCTZ 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SY] · Amlodipine 5 MG / HCTZ 25 MG / Olmesartan medoxomil 40 MG Oral Tablet [SY] | 4 | 23 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | 20260331 |
| 5c128ef2-60a6-40f3-b37f-ee139fe27987 | olmesartan medoxomil 40 MG / amLODIPine 5 MG / hydroCHLOROthiazide 25 MG Oral Tablet [PSN] · amlodipine 5 MG / hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SCD] · amlodipine (as amlodipine besilate) 5 MG / HCTZ 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SY] · Amlodipine 5 MG / HCTZ 25 MG / Olmesartan medoxomil 40 MG Oral Tablet [SY] | 4 | 14 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE, AND HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE, AND HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE, AND HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | 20210101 |
| 9fb71df8-f70f-47dc-9465-8d8748261caf | olmesartan medoxomil 40 MG / amLODIPine 5 MG / hydroCHLOROthiazide 25 MG Oral Tablet [PSN] · amlodipine 5 MG / hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SCD] · amlodipine (as amlodipine besilate) 5 MG / HCTZ 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SY] · Amlodipine 5 MG / HCTZ 25 MG / Olmesartan medoxomil 40 MG Oral Tablet [SY] | 4 | 5 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | 20251129 |
| 57ffeef7-bfa8-4f92-aadc-23cd00022607 | olmesartan medoxomil 40 MG / amLODIPine 5 MG / hydroCHLOROthiazide 25 MG Oral Tablet [PSN] · amlodipine 5 MG / hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SCD] · amlodipine (as amlodipine besilate) 5 MG / HCTZ 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SY] · Amlodipine 5 MG / HCTZ 25 MG / Olmesartan medoxomil 40 MG Oral Tablet [SY] | 4 | 3 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | 20260107 |
| a469adff-25a6-4983-b471-60924d920a86 | olmesartan medoxomil 40 MG / amLODIPine 5 MG / hydroCHLOROthiazide 25 MG Oral Tablet [PSN] · amlodipine 5 MG / hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SCD] · amlodipine (as amlodipine besilate) 5 MG / HCTZ 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SY] · Amlodipine 5 MG / HCTZ 25 MG / Olmesartan medoxomil 40 MG Oral Tablet [SY] | 4 | 3 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE, and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE, and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE, and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | 20250630 |
| 2f56d0bc-236b-41a0-9fc0-21cdfea8d890 | olmesartan medoxomil 40 MG / amLODIPine 5 MG / hydroCHLOROthiazide 25 MG Oral Tablet [PSN] · amlodipine 5 MG / hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SCD] · amlodipine (as amlodipine besilate) 5 MG / HCTZ 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SY] · Amlodipine 5 MG / HCTZ 25 MG / Olmesartan medoxomil 40 MG Oral Tablet [SY] | 4 | 3 | These highlights do not include all the information needed to use TRIBENZOR safely and effectively. See full prescribing information for TRIBENZOR. TRIBENZOR (olmesartan medoxomil, amlodipine, hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 2010 | 20230712 |
| 45e975ff-07b1-411a-96ee-a011d1619b1e | olmesartan medoxomil 40 MG / amLODIPine 5 MG / hydroCHLOROthiazide 25 MG Oral Tablet [PSN] · amlodipine 5 MG / hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SCD] · amlodipine (as amlodipine besilate) 5 MG / HCTZ 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SY] · Amlodipine 5 MG / HCTZ 25 MG / Olmesartan medoxomil 40 MG Oral Tablet [SY] | 4 | 1 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | 20260105 |
| 52c013e1-8c31-4bed-9241-e7845873ebe8 | olmesartan medoxomil 40 MG / amLODIPine 5 MG / hydroCHLOROthiazide 25 MG Oral Tablet [PSN] · amlodipine 5 MG / hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SCD] · amlodipine (as amlodipine besilate) 5 MG / HCTZ 25 MG / olmesartan medoxomil 40 MG Oral Tablet [SY] · Amlodipine 5 MG / HCTZ 25 MG / Olmesartan medoxomil 40 MG Oral Tablet [SY] | 4 | 1 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | 20250804 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 57ffeef7-bfa8-4f92-aadc-23cd00022607 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | REMEDYREPACK INC. | 20261019 |
| 268d12e8-1cfc-4086-b613-8fd94f2d7c4e | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | Par Health USA, LLC | 20260911 |
| 57ffeef7-bfa8-4f92-aadc-23cd00022607 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | REMEDYREPACK INC. | 20260828 |
| 268d12e8-1cfc-4086-b613-8fd94f2d7c4e | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | Par Health USA, LLC | 20260331 |
| 57ffeef7-bfa8-4f92-aadc-23cd00022607 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | REMEDYREPACK INC. | 20260107 |
| 45e975ff-07b1-411a-96ee-a011d1619b1e | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 20260105 |
| 9fb71df8-f70f-47dc-9465-8d8748261caf | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | Micro Labs Limited | 20251129 |
| 52c013e1-8c31-4bed-9241-e7845873ebe8 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | Macleods Pharmaceuticals Limited | 20250804 |
| 85b8f9c6-aa53-4aa1-85d6-19f823d0d252 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS, for oral use Initial U.S. Approval: 2010 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. | 20250717 |
| a469adff-25a6-4983-b471-60924d920a86 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE, and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE, and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE, and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | Slate Run Pharmaceuticals, LLC | Piramal Pharma Limited | 20250630 |
| 49ec5ac8-a626-4ab2-9799-8a138920201e | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS Tablets, for oral use Initial U.S. Approval: 2010 | Bryant Ranch Prepack | 20241106 |
| be69f132-8b77-4590-a688-cb3709649466 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE TABLETS Tablets, for oral use Initial U.S. Approval: 2010 | Bryant Ranch Prepack | 20240806 |
| 663c1219-6064-4dab-bd47-49b79e41880d | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | REMEDYREPACK INC. | 20240222 |
| ee828a36-7f94-4106-8c4d-c61ba7e2f308 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | Sun Pharmaceutical Industries, Inc. | 20220713 |
| 81efddea-b57c-4e5c-a1e3-bb4c29912b58 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS, for oral use Initial U.S. Approval: 2010 | REMEDYREPACK INC. | 20210915 |
| 5c128ef2-60a6-40f3-b37f-ee139fe27987 | These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE, AND HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE, AND HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL, AMLODIPINE, AND HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010 | Teva Pharmaceuticals USA, Inc. | 20210101 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C09CA | Angiotensin II receptor blockers (ARBs), plain | ATC1-4 | olmesartan medoxomil | |
| ATC | C08CA | Dihydropyridine derivatives | ATC1-4 | amlodipine | |
| ATC | C03AA | Thiazides, plain | ATC1-4 | hydrochlorothiazide | |
| FDASPL | D004095 | Dihydropyridines | CHEM | has_chemical_structure | amlodipine |
| FDASPL | D049971 | Thiazides | CHEM | has_chemical_structure | hydrochlorothiazide |
| FDASPL | N0000175561 | Angiotensin 2 Receptor Blocker | EPC | has_epc | olmesartan |
| FDASPL | N0000175566 | Calcium Channel Blocker | EPC | has_epc | amlodipine |
| FDASPL | N0000175421 | Dihydropyridine Calcium Channel Blocker | EPC | has_epc | amlodipine |
| FDASPL | N0000175419 | Thiazide Diuretic | EPC | has_epc | hydrochlorothiazide |
| FDASPL | N0000000070 | Angiotensin 2 Receptor Antagonists | MOA | has_moa | olmesartan |
| FDASPL | N0000000069 | Calcium Channel Antagonists | MOA | has_moa | amlodipine |
| FDASPL | N0000190114 | Cytochrome P450 3A Inhibitors | MOA | has_moa | amlodipine |
| FDASPL | N0000175359 | Increased Diuresis | PE | has_pe | hydrochlorothiazide |
| MEDRT | D017311 | Amlodipine | CHEM | has_ingredient | amlodipine |
| MEDRT | D006852 | Hydrochlorothiazide | CHEM | has_ingredient | hydrochlorothiazide |
| MEDRT | D007093 | Imidazoles | CHEM | has_ingredient | olmesartan |
| MEDRT | D000068557 | Olmesartan Medoxomil | CHEM | has_ingredient | olmesartan medoxomil |
| MEDRT | D013449 | Sulfonamides | CHEM | ci_chemclass | hydrochlorothiazide |
| MEDRT | D013777 | Tetrazoles | CHEM | has_ingredient | olmesartan |
| MEDRT | D000788 | Angina Pectoris, Variant | DISEASE | may_treat | amlodipine |
| MEDRT | D001002 | Anuria | DISEASE | ci_with | hydrochlorothiazide |
| MEDRT | D003324 | Coronary Artery Disease | DISEASE | may_treat | amlodipine |
| MEDRT | D003928 | Diabetic Nephropathies | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | D003928 | Diabetic Nephropathies | DISEASE | may_treat | olmesartan |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | amlodipine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | hydrochlorothiazide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | olmesartan |
| MEDRT | D004487 | Edema | DISEASE | may_treat | hydrochlorothiazide |
| MEDRT | D006333 | Heart Failure | DISEASE | may_treat | hydrochlorothiazide |
| MEDRT | D006333 | Heart Failure | DISEASE | may_treat | olmesartan |
| MEDRT | D006333 | Heart Failure | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | D006929 | Hyperaldosteronism | DISEASE | ci_with | olmesartan |
| MEDRT | D006929 | Hyperaldosteronism | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | olmesartan |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | hydrochlorothiazide |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | amlodipine |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | olmesartan |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | amlodipine |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | hydrochlorothiazide |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | olmesartan |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | hydrochlorothiazide |
| MEDRT | D051437 | Renal Insufficiency | DISEASE | ci_with | hydrochlorothiazide |
| MEDRT | D018487 | Ventricular Dysfunction, Left | DISEASE | may_treat | olmesartan |
| MEDRT | D018487 | Ventricular Dysfunction, Left | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | N0000000070 | Angiotensin 2 Receptor Antagonists | MOA | has_moa | olmesartan |
| MEDRT | N0000000070 | Angiotensin 2 Receptor Antagonists | MOA | has_moa | olmesartan medoxomil |
| MEDRT | N0000020065 | L-Calcium Channel Receptor Antagonists | MOA | has_moa | amlodipine |
| MEDRT | N0000181005 | Sodium Chloride Symporter Inhibitors | MOA | has_moa | hydrochlorothiazide |
| MEDRT | N0000008375 | Coronary Arterial Vasodilation | PE | has_pe | amlodipine |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | ci_pe | amlodipine |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | hydrochlorothiazide |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | amlodipine |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | olmesartan |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000008579 | Decreased Distal Tubule Ca++ Excretion | PE | has_pe | hydrochlorothiazide |
| MEDRT | N0000008669 | Decreased Intravascular Volume | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000008669 | Decreased Intravascular Volume | PE | has_pe | olmesartan |
| MEDRT | N0000008669 | Decreased Intravascular Volume | PE | has_pe | hydrochlorothiazide |
| MEDRT | N0000008731 | Decreased Mineralocorticoid Secretion | PE | has_pe | olmesartan |
| MEDRT | N0000008731 | Decreased Mineralocorticoid Secretion | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000008859 | Decreased Renal K+ Excretion | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000008859 | Decreased Renal K+ Excretion | PE | has_pe | olmesartan |
| MEDRT | N0000009274 | Increased Distal Tubule Cl- Excretion | PE | has_pe | hydrochlorothiazide |
| MEDRT | N0000009275 | Increased Distal Tubule H+ Excretion | PE | has_pe | hydrochlorothiazide |
| MEDRT | N0000009277 | Increased Distal Tubule K+ Excretion | PE | has_pe | hydrochlorothiazide |
| MEDRT | N0000009279 | Increased Distal Tubule Na+ Excretion | PE | has_pe | hydrochlorothiazide |
| MEDRT | N0000175359 | Increased Diuresis | PE | has_pe | hydrochlorothiazide |
| MEDRT | N0000009553 | Increased Renal Na+ Excretion | PE | has_pe | olmesartan |
| MEDRT | N0000009553 | Increased Renal Na+ Excretion | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000009825 | Renal Arterial Vasoconstriction | PE | ci_pe | olmesartan |
| MEDRT | N0000009825 | Renal Arterial Vasoconstriction | PE | ci_pe | olmesartan medoxomil |
| MEDRT | N0000009826 | Renal Arterial Vasodilation | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000009826 | Renal Arterial Vasodilation | PE | has_pe | olmesartan |
| MEDRT | N0000009909 | Vasodilation | PE | has_pe | hydrochlorothiazide |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | hydrochlorothiazide |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 5 MG / 25 MG / 40 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA202491 |
| CODES | ANDA | ANDA206137 |
| CODES | ANDA | ANDA207088 |
| CODES | ANDA | ANDA207437 |
| CODES | ANDA | ANDA209242 |
| CODES | ANDA | ANDA210718 |
| CODES | SNOMEDCT | 447089002 |
| CODES | VUID | 4030080 |
| NAMES | Prescribable Synonym | olmesartan medoxomil 40 MG / amLODIPine 5 MG / hydroCHLOROthiazide 25 MG Oral Tablet |
| NAMES | Tallman Synonym | amLODIPine (as amLODIPine besilate) 5 MG / HCTZ 25 MG / olmesartan medoxomil 40 MG Oral Tablet |
| NAMES | Tallman Synonym | amLODIPine 5 MG / HCTZ 25 MG / Olmesartan medoxomil 40 MG Oral Tablet |
| NAMES | Tallman Synonym | amLODIPine 5 MG / hydroCHLOROthiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |